OpenBilldrug price receipt

NADAC week of 2026-10-14

CARBIDOPA-LEVO ER 50-200 TAB

For 30 tablets

Pharmacies pay

$5.39 filed

30 × $0.17959 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$10.70 filed

30 × $0.35658 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

2.0× estimated

Medicare paid 2.0× what pharmacies pay.

Part D averages every strength and form sold under “Carbidopa-Levodopa ER” / “Carbidopa/Levodopa” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$11.20 estimated

$5.39 + $0.81 (15%) + $5.00 fee per fill = $11.20

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

CARBIDOPA-LEVO ER 50-200 TAB is how the CMS NADAC file names this product. The FDA NDC Directory lists it as carbidopa and levodopa.

FDA gives its dosage form as tablet, extended release and its route as oral.

FDA lists 5 labelers (the companies named on the label) for its NDCs, among them Mylan Pharmaceuticals Inc., ScieGen Pharmaceuticals Inc and Mylan Institutional Inc.

FDA’s Established Pharmacologic Class for it is Aromatic Amino Acid.

The NADAC file of 2026-10-14 prices it under 8 NDCs (National Drug Codes); the FDA directory lists 7 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $5.39 for 30 tablets (30 × $0.17959 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 5 labelers

LabelerNDCsPharmacies pay per unit
Advagen Pharma Ltd2$0.17959 per EA filed
ScieGen Pharmaceuticals Inc2$0.17959 per EA filed
Amneal Pharmaceuticals NY LLC1$0.17959 per EA filed
Mylan Institutional Inc.1$0.17959 per EA filed
Mylan Pharmaceuticals Inc.1$0.17959 per EA filed
Not listed as a package in the FDA directory1$0.17959 per EA filed
All 8 NDCs, with labeler and price
  • 00378-0094-01 · Mylan Pharmaceuticals Inc. · $0.17959 per EA · eff. 2026-09-23 filed
  • 50228-0461-01 · ScieGen Pharmaceuticals Inc · $0.17959 per EA · eff. 2026-09-23 filed
  • 50228-0461-10 · ScieGen Pharmaceuticals Inc · $0.17959 per EA · eff. 2026-09-23 filed
  • 51079-0923-01 · not listed as a package in the FDA directory · $0.17959 per EA · eff. 2026-09-23 filed
  • 51079-0923-20 · Mylan Institutional Inc. · $0.17959 per EA · eff. 2026-09-23 filed
  • 60219-2034-01 · Amneal Pharmaceuticals NY LLC · $0.17959 per EA · eff. 2026-09-23 filed
  • 72888-0156-01 · Advagen Pharma Ltd · $0.17959 per EA · eff. 2026-09-23 filed
  • 72888-0156-30 · Advagen Pharma Ltd · $0.17959 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

18 other products in the NADAC file share the FDA nonproprietary name carbidopa and levodopa with CARBIDOPA-LEVO ER 50-200 TAB.

ProductPharmacies pay per unitMedicare per unit
CARBIDOPA-LEVO 25-100 MG ODT
generic · tablet, orally disintegrating
$0.68655 per EA filed
eff. 2026-09-23
We don’t know yet
CARBIDOPA-LEVO ER 23.75-95 CAP
generic · capsule, extended release
$3.15323 per EA filed
eff. 2026-09-23
$0.35658 per EA filed
Part D 2024 average
CARBIDOPA-LEVO ER 25-100 TAB
generic · tablet, extended release
$0.11014 per EA filed
eff. 2026-09-23
$0.35658 per EA filed
Part D 2024 average
CARBIDOPA-LEVO ER 36.25-145 CP
generic · capsule, extended release
$3.3941 per EA filed
eff. 2026-09-23
$0.35658 per EA filed
Part D 2024 average
CARBIDOPA-LEVO ER 48.75-195 CP
generic · capsule, extended release
$3.18794 per EA filed
eff. 2026-09-23
$0.35658 per EA filed
Part D 2024 average
CARBIDOPA-LEVO ER 50-200 TAB this page
generic · tablet, extended release
$0.17959 per EA filed
eff. 2026-09-23
$0.35658 per EA filed
Part D 2024 average
CARBIDOPA-LEVO ER 61.25-245 CP
generic · capsule, extended release
$3.92786 per EA filed
eff. 2026-09-23
$0.35658 per EA filed
Part D 2024 average
CARBIDOPA-LEVODOPA 10-100 TAB
generic · tablet
$0.06826 per EA filed
eff. 2026-09-23
$0.138 per EA filed
Part D 2024 average
CARBIDOPA-LEVODOPA 25-100 TAB
generic · tablet
$0.07589 per EA filed
eff. 2026-09-23
$0.138 per EA filed
Part D 2024 average
CARBIDOPA-LEVODOPA 25-250 TAB
generic · tablet
$0.11894 per EA filed
eff. 2026-09-23
$0.138 per EA filed
Part D 2024 average
CREXONT ER 35 MG-140 MG CAP
brand · capsule, extended release
$4.58989 per EA filed
eff. 2026-07-01
We don’t know yet
CREXONT ER 52.5 MG-210 MG CAP
brand · capsule, extended release
$4.5824 per EA filed
eff. 2026-07-01
We don’t know yet
CREXONT ER 70 MG-280 MG CAP
brand · capsule, extended release
$4.58002 per EA filed
eff. 2026-07-01
We don’t know yet
CREXONT ER 87.5 MG-350 MG CAP
brand · capsule, extended release
$4.58252 per EA filed
eff. 2026-07-01
We don’t know yet
RYTARY ER 23.75 MG-95 MG CAP
brand · capsule, extended release
$3.98069 per EA filed
eff. 2026-09-23
We don’t know yet
RYTARY ER 36.25 MG-145 MG CAP
brand · capsule, extended release
$3.9763 per EA filed
eff. 2026-09-23
We don’t know yet
RYTARY ER 48.75 MG-195 MG CAP
brand · capsule, extended release
$3.98378 per EA filed
eff. 2026-09-23
We don’t know yet
RYTARY ER 61.25 MG-245 MG CAP
brand · capsule, extended release
$4.99716 per EA filed
eff. 2026-09-23
We don’t know yet
SINEMET 25-100 MG TABLET
brand · tablet
$1.42358 per EA filed
eff. 2026-01-01
$1.28606 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-01-01, 2026-07-01, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 8 NDCs’ NADAC prices is $0.17959 per EA filed.

Of the 25 other products in FDA’s Aromatic Amino Acid class priced per EA, 21 have a higher middle NADAC price and 4 a lower one. The one in the middle is CARBIDOPA-LEVO ER 23.75-95 CAP, at $3.15323 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $10.70 for 30 tablets, at an average of $0.35658 per EA in 2024 (2024-01-01 to 2024-12-31) for “Carbidopa-Levodopa ER” and “Carbidopa/Levodopa”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 604,966 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for CARBIDOPA-LEVO ER 50-200 TAB labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Carbidopa-Levodopa ER / Carbidopa/Levodopa: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.